FDA Inspection
Symbiosis Pharmaceutical Services LimitedSymbiosis Pharmaceutical Services Limited – FDA Inspection, Feb 23, 2018
Record Details
This FDA Inspection record concerns Symbiosis Pharmaceutical Services Limited, with an inspection on February 23, 2018, issued by the Office of Inspections and Investigations, covering biologics.
- Inspection Date
- February 23, 2018
- Product Type
- Biologics
- People
- Andrew P. Byrnes (Issuing Officer)
- Christine Harman (Investigator)
- Wei Wang (Company Rep)
View Company Profile
ID · b7424c57-dedf-4bc7-87af-c5f82cc3f66d
Inspection Facts
- Inspection number
- 1045937
- FDA center
- Biologics
- Outcome
- Form 483 issued
Other FDA inspections of Symbiosis Pharmaceutical Services Limited
2| Date | Classification | Office | Project area |
|---|---|---|---|
| January 31, 2025 | Not classified | Office of Inspections and Investigations | |
| June 13, 2023 | VAI | Office of Inspections and Investigations |
Other documents for Symbiosis Pharmaceutical Services Limited
- FDA Inspection 1266061 - 2025-01-31
- FDA Inspection 1208076 - 2023-06-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.